Vaccine Side Effects in Health Care Workers after Vaccination against SARS-CoV-2: Data from TüSeRe:exact Study

• Published in: Viruses Vol. 15; no. 1; p. 65
• Main Authors: Bareiß, Alan, Uzun, Günalp, Mikus, Marco, Becker, Matthias, Althaus, Karina, Schneiderhan-Marra, Nicole, Fürstberger, Axel, Schwab, Julian D, Kestler, Hans A, Holderried, Martin, Martus, Peter, Schenke-Layland, Katja, Bakchoul, Tamam
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 25.12.2022; MDPI
• Subjects: 2019-nCoV Vaccine mRNA-1273; Adult; adverse event; Age; BNT162 Vaccine; ChAdOx1 nCoV-19; Coronaviruses; COVID-19; COVID-19 - prevention & control; COVID-19 vaccines; COVID-19 Vaccines - adverse effects; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Erythema; Female; Fever; Generalized linear models; Health Personnel; Humans; Immunization; Male; Medical personnel; Middle Aged; mRNA; Multivariate analysis; Muscle pain; Nausea; reactogenicity; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Side effects; Vaccination - adverse effects; vaccine; Vaccines; United States > US; Central Europe; China; Germany; COVID-19; adverse event; vaccine; reactogenicity
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v15010065

As the Corona Disease 2019 (COVID-19) caused by SARS-CoV-2 persists, vaccination is one of the key measures to contain the spread. Side effects (SE) from vaccination are one of the reasons for reluctance to vaccinate. We systematically investigated self-reported SE after the first, second, and booster vaccinations. The data were collected during the TüSeRe: exact study (Tübinger Monitoring Studie zur exakten Analyse der Immunantwort nach Vakzinierung). Employees of health and research institutions were invited to participate. Study participants were asked to fill out an online questionnaire and report their SE after each dose of SARS-CoV-2 vaccination. A total of 1046 participants (mean age: 44 ± 12.9 years; female, = 815 (78%); male, = 231 (22%)) were included in the analysis. Local and systemic SE were more frequent after receiving the vector-based vaccine ChAdOx1 nCoV-19 in the first vaccination. However, local and systemic SE were more common after receiving mRNA vaccines (BNT162b2, mRNA-1273) in the second vaccination. Compared to the BNT162b2 vaccine, more SE have been observed after receiving the mRNA-1273 vaccine in the booster vaccination. In multivariate analysis, local and systemic side effects were associated with vaccine type, age and gender. Local and systemic SE are common after SARS-CoV-2 vaccines. The frequency of self-reported local and systemic SE differ significantly between mRNA and vector-based vaccines.